The sun has been shining on the biopharmaceutical sector of late as investors have returned to the sector big time. As a result, the BioWorld Biopharmaceutical index grew a healthy 6.6 percent in the second quarter, well ahead of the general markets, thanks to a late June spurt in valuations, causing the index to grow 5.8 percent last month.